Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach

[1]  S. Mavrogeni,et al.  Myocarditis in a patient with Duchenne muscular dystrophy detected by cardiovascular magnetic resonance and cardiac biopsy. , 2009, International journal of cardiology.

[2]  M. Cheitlin.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2009 .

[3]  G. Sutherland,et al.  Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[4]  E. McNally.  Duchenne muscular dystrophy: how bad is the heart? , 2008, Heart.

[5]  E. Niggli,et al.  Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways. , 2008, Cardiovascular research.

[6]  K. Klingel,et al.  Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis , 2008, Heart.

[7]  A. Maisel,et al.  State-of-the-Art PaperNatriuretic Peptides , 2007 .

[8]  J. Towbin,et al.  Myocardial infarction, viral infection, and the cytoskeleton final common pathways of a common disease? , 2007, Journal of the American College of Cardiology.

[9]  A. Kerr,et al.  B-type natriuretic peptide and left ventricular dysfunction on exercise echocardiography in patients with chronic aortic regurgitation , 2007, Heart.

[10]  J. Dyck,et al.  Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy. , 2007, Journal of molecular and cellular cardiology.

[11]  C. Rochitte,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. , 2007, Journal of the American College of Cardiology.

[12]  Petros Syrris,et al.  Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.

[13]  N. Dalton,et al.  Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy , 2006, Circulation.

[14]  Vincenzo Giglio,et al.  Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. , 2007, The American journal of cardiology.

[15]  K. Klingel,et al.  Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis , 2006, Circulation.

[16]  M. Jessup,et al.  Stage B Heart Failure: Management of Asymptomatic Left Ventricular Systolic Dysfunction , 2006, Circulation.

[17]  R. Ohye,et al.  Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Jefferies J, Eidem B, Belmont J, Craigen W, Ware S, Fernbach S, Neish S, Smith E, Towbin J (2005) Circulation 112: 2799-2804: Commentary , 2005 .

[18]  J. Belmont,et al.  Genetic Predictors and Remodeling of Dilated Cardiomyopathy in Muscular Dystrophy , 2005, Circulation.

[19]  S. Caruthers,et al.  Occult Cardiac Contractile Dysfunction in Dystrophin-Deficient Children Revealed by Cardiac Magnetic Resonance Strain Imaging , 2005, Circulation.

[20]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[21]  R. Kim,et al.  Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.

[22]  H. Bécane,et al.  Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. , 2005, Journal of the American College of Cardiology.

[23]  D. Pennell,et al.  Late gadolinium enhanced cardiovascular magnetic resonance in Becker muscular dystrophy , 2004, Heart.

[24]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[25]  C. Badorff,et al.  Dystrophin disruption in enterovirus-induced myocarditis and dilated cardiomyopathy: from bench to bedside , 2004, Medical Microbiology and Immunology.

[26]  A. Kerr,et al.  Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. , 2003, Journal of the American College of Cardiology.

[27]  Pedro Lozano.  Natriuretic peptides. , 2020, The Journal of the Arkansas Medical Society.

[28]  O. Simonetti,et al.  An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.

[29]  C. Badorff,et al.  Dissociation of Sarcoglycans and the Dystrophin Carboxyl Terminus From the Sarcolemma in Enteroviral Cardiomyopathy , 2000, Circulation research.

[30]  Neil E. Bowles,et al.  The “Final Common Pathway” Hypothesis and Inherited Cardiovascular Disease The Role of Cytoskeletal Proteins in Dilated Cardiomyopathy , 2000, Herz.

[31]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[32]  L. Kunkel,et al.  Dystrophies and heart disease. , 1997, Current opinion in cardiology.

[33]  G. Danieli,et al.  Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. , 1996, Circulation.

[34]  L. Politano,et al.  Evaluation of the cardiomyopathy in becker muscular dystrophy , 1995, Muscle & nerve.

[35]  M. Thambyayah,et al.  Prevalence and incidence of Becker muscular dystrophy , 1991, The Lancet.

[36]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[37]  E. Henze,et al.  Alterations in regional myocardial metabolism, perfusion, and wall motion in Duchenne muscular dystrophy studied by radionuclide imaging. , 1984, Circulation.

[38]  S. Pitner,et al.  An Ultrastructural Basis for Electrocardiographic Alterations Associated with Duchenne's Progressive Muscular Dystrophy , 1978, Circulation.

[39]  K. Frankel,et al.  The pathology of the heart in progressive muscular dystrophy: epimyocardial fibrosis. , 1976, Human pathology.

[40]  W. Roberts,et al.  The distinctive electrocardiogram of Duchenne's progressive muscular dystrophy. An electrocardiographic-pathologic correlative study. , 1967, The American journal of medicine.